DEJOURA Trademark

Trademark Overview

On Monday, October 2, 2017, a trademark application was filed for DEJOURA with the United States Patent and Trademark Office. The USPTO has given the DEJOURA trademark a serial number of 87630214. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 5, 2021. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The DEJOURA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications
dejoura

General Information

Serial Number87630214
Word MarkDEJOURA
Filing DateMonday, October 2, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 6, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Monday, April 5, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 5, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020EXTENSION 5 GRANTED
Thursday, August 20, 2020EXTENSION 5 FILED
Monday, August 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 20, 2020TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 20, 2020EXTENSION 4 GRANTED
Thursday, February 20, 2020EXTENSION 4 FILED
Thursday, February 20, 2020TEAS EXTENSION RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2019EXTENSION 3 GRANTED
Tuesday, August 20, 2019EXTENSION 3 FILED
Tuesday, August 20, 2019TEAS EXTENSION RECEIVED
Friday, February 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 20, 2019EXTENSION 2 GRANTED
Wednesday, February 20, 2019EXTENSION 2 FILED
Wednesday, February 20, 2019TEAS EXTENSION RECEIVED
Wednesday, August 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2018EXTENSION 1 GRANTED
Monday, August 20, 2018EXTENSION 1 FILED
Monday, August 20, 2018TEAS EXTENSION RECEIVED
Tuesday, February 27, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 2, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 22, 2017ASSIGNED TO LIE
Thursday, November 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 9, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, November 9, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 9, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, November 9, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, November 3, 2017ASSIGNED TO EXAMINER
Friday, October 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 5, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

dejoura women hormone replacement medications contraceptives injectable preparations namely oral pharmaceutical